QA: GeneDx Holdings Corp. in us_health_services/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001818331_2023_GeneDx_Holdings_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001818331, GeneDx Holdings Corp.

  xvar xval
0 IntangibleAssets 186,650,000
1 AssetsNonCurrent 39,243,000
2 AssetsCurrent 212,622,000
3 PropertyPlantAndEquipment 51,527,000
4 remainder_Assets 900,000
5 LongTermLiabilities 28,250,000
6 LiabilitiesCurrent 146,956,000
7 remainder_Liabilities 62,031,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 261,444,000
10 GeneralAndAdministrativeExpense 203,329,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 134,913,000
15 ResearchAndDevelopmentExpense 86,203,000
16 remainder_Expenses 167,405,000
17 remainder_Revenues 234,694,000
18 remainder_NetIncome 69,620,000
19 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 490,942,000
1 Liabilities 237,237,000
2 Expenses 853,294,000
3 Revenues 234,694,000
4 StockholdersEquity 253,705,000
5 NetIncome -548,980,000
6 ComprehensiveNetIncome -548,980,000
7 BaseVar 1,133,898,820
8 EconomicCapitalRatio -0.828

Edgar->Model Mapping

Feature Distribution

Change over Time